Leadership Proven in Oncology Development
Seasoned executives and scientific leaders with deep expertise in drug development, clinical execution, and capital markets.
Neil Thapar, PharmD
Co-founder, Board Chairman, CEO & CSO
Dr. Thapar is a clinical pharmacologist with over 20 years of experience in oncology drug development. He completed a post-doctoral fellowship in oncology drug research & development at The University of Texas MD Anderson Cancer Center, focusing on translating scientific insights into innovative therapies.
Prior to Barricade, Dr. Thapar worked on synthetic triterpenoid programs at Reata Pharmaceuticals as part of the company’s scientific and development teams during a period in which Reata completed an initial public offering and was later acquired by Biogen. His work is dedicated to advancing safer and more effective cancer treatments through evidence-based clinical pharmacology.
John Walling, PhD
Co-Founder, SVP Chemistry, Manufacturing & Controls
Dr. Walling is a co-founder and organic chemist with over 35 years of experience. He holds multiple patents and has a strong track record in commercialization, driving innovation from concept to market.
Mariam Morris
Chief Operating Officer
Mariam E. Morris supports Barricade’s executive leadership as a strategic advisor on corporate operations, financial strategy, and governance as the company scales. With more than 25 years of executive and advisory experience, she provides guidance across financial planning, capital strategy, compliance and public-company readiness, and complex transactions, including financings and M&A.
She works closely with management and the Board to strengthen operational infrastructure, ensure financial rigor, and guide the company through key growth and transformation milestones.
Scott Jordan
Chief Financial Officer, FINRA Licensed
Scott Jordan is a strategic advisor and investment banker with extensive experience in capital raising and successful exits, including public listings. He has served as CFO and CBO of both public and private biotech companies.
Mr. Jordan’s expertise also includes business development and managing complex cross-border transactions.
Darlene Boudreaux, MBA, CPA
Board of Directors
Darlene Boudreaux is the CFO and Founder/CEO of PharmaFab. Previously, she served as Executive Director at TechFW. Mrs. Boudreaux has been instrumental in multiple successful exits, including ZS Pharma and Encore Vision.
She currently serves on Barricade’s Board of Directors, providing strategic guidance on corporate matters.
Board of Directors
Dr. Guillem is President of Western Son Distillery and co-founder of CarGin Enterprises. He also serves on the boards of Barricade Therapeutics and Renibus Therapeutics.